Training scientists from low- and middle-income countries in HIV prevention research
International Traineeships in AIDS Prevention Studies (ITAPS)
This program helps early-career scientists from low- and middle-income countries improve their research skills in HIV prevention, so they can create effective strategies that work best for their communities.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-10802349 on NIH RePORTER |
What this research studies
The International Traineeships in AIDS Prevention Studies (ITAPS) program at the University of California, San Francisco focuses on enhancing the research skills of early-career scientists from low- and middle-income countries engaged in HIV research. This program provides mentorship, applied research experiences, and training in data analysis and manuscript writing to help these scientists develop effective HIV prevention strategies tailored to their local contexts. By fostering local expertise, the program aims to empower these researchers to lead future studies and contribute to the global fight against HIV.
Who could benefit from this research
Good fit: Ideal candidates for this research are early-career scientists from low- and middle-income countries who are involved in HIV research.
Not a fit: Patients who are not involved in HIV research or are from high-income countries may not receive direct benefits from this program.
Why it matters
Potential benefit: If successful, this research could significantly improve the capacity of local scientists to develop and implement effective HIV prevention strategies in their communities.
How similar studies have performed: Previous iterations of the ITAPS program have successfully trained hundreds of investigators and contributed to significant advancements in HIV research.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Lindan, Christina P — University of California, San Francisco
- Study coordinator: Lindan, Christina P
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.